CD8A and infection: Clinical trials and animal studies of the currently licensed human flavivirus vaccines further support that T cells, in particular, multifunctional CD4+ and CD8+ memory T cell responses which have similar magnitude, frequency and specificity as those of natural infection contribute to a safe, efficacious and durable vaccine.